Daniel Zaghi MD

Dermatology

Summary

Dr. Daniel Zaghi MD MS FAAD is a full-time board-certified dermatologist in Los Angeles, California, specializing in complex medical dermatology and cosmetic dermatology. He received his medical degree from David Geffen School of Medicine at UCLA. His interests in clinical research and pipeline therapeutics compelled him to obtain a Master's Degree in Clinical Investigation, which included the rigorous study of clinical trial design, epidemiology and biostatistics. Thusly, unlike most of his peers, Dr. Zaghi is uniquely able to interpret published research findings and accurately predict the impact of pipeline and FDA-approved therapies/MOAs on the dermatology landscape.

Dr. Zaghi has been in full time practice since 2015 and is experienced in many complicated dermatoses, including psoriasis, atopic dermatitis, hidradenitis suppurativa, vitiligo, pemphigus and alopecia areata. He is a former National Psoriasis Foundation research award recipient and has worked in multiple clinical trials of drugs now FDA approved in dermatology. He additionally has extensive training and practice in cosmetic dermatology and energy-based devices. He is considered a key opinion leader in many inflammatory dermatoses and he has more than 20 publications and 45 citings.

Baylor University Medical CenterResidency, Dermatology, 2012 - 2015
University of UtahMS, Clinical Investigation, 2010 - 2012
Stanford Health Care-Sponsored Stanford UniversityResidency, Anesthesiology, 2009 - 2010
Santa Clara Valley Medical CenterInternship, Internal Medicine, 2007 - 2008
David Geffen School of Medicine at UCLAClass of 2007
UC DavisBS, Neurobiology, Physiology and Behavior, Summa Cum Laude, 1997 - 2001

PubMed

3 citations
Defining "Lichen": From Greek Mycology to Modern Dermatology
Daniel Zaghi, John R. Griffin
JAMA Dermatology. 2016-10-01
1 citations
Desired Improvement Tool (DIT): A tool to assess desire for improvement in psoriasis patients.
Daniel Zaghi, Charlene R. Weir, Jian Ying, Christopher S. Carlin, Tom Greene
The Journal of Dermatological Treatment. 2015-08-06
12 citations
Emerging oral drugs for psoriasis.
Tahmina Mahmood, Daniel Zaghi, Alan Menter
Expert Opinion on Emerging Drugs. 2015-05-22

Journal Articles

Polymorphic Plaques on the Face and Extremities
Zaghi D, Withheiler D, Menter A, Journal of the American Medical Association (JAMA) Dermatology, 7/1/2014
Psoriasis: What Every Resident Needs to Know
Zaghi D, Ryan C, Directions in Residency: Official Publication of the Residents/Fellow Committee, American Academy of Dermatology, 1/1/2014
Liver Spots: What You Need to Know
Zaghi D, Scrubbing In. Hands-On Health Care Discussions, Baylor Health Care System, 1/1/2014
Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis
Zaghi D, Krueger GG, Callis Duffin K, Journal of drugs in dermatology : JDD, 2/1/2012
The Role of Selenium in the Fight against Prostate Cancer in American Men
Zaghi D, Nutrition Bytes, 1/1/2003
Form and function offetal and neonatal pulmonary arterial bifurcations
Bennett SH, Eldridge MW, Zaghi D, Goetzman BW, American journal of physiology. Heart and circulatory physiology, 12/1/2000
Join now to see all

Books/Book Chapters

Manual of Clinical Anesthesiology
Chapter: Restrictive Lung Disease
Zaghi DEditors: L.F. Chu & A.J. Fuller.Lippincott Williams & Wilkins, Philadelphia, PA2012

Abstracts/Posters

Hansen’s Disease
Zaghi D, Texas Dermatology Society, 1/1/2014
Pityriasis Ruba Pilaris, Atypical Juvenile Onset
Zaghi D, Texas Dermatology Society, 1/1/2014
The Desired Improvement Tool: A Tool to Assess Desire for Improvement in Psoriasis Patients
Zaghi D, Weir C, Ying J, et al, Winter Clinical Dermatology Conference, 1/1/2014
Response of Angiofibromas in Tuberous Sclerosis to C02 Laser
Zaghi D, Oral presentation. Cosmetic Surgery Forum, 1/1/2013
The Desired Improvement Tool: A Tool to Assess Desire for Improvement in Psoriasis Patients
Zaghi D, Weir C, Ying J, et al, Society of Investigative Dermatology, 1/1/2012
Heavy Smoking in Psoriasis Patients Delays Age of Onset of Psoriatic Arthritis and May Protect Against Disease Development
Heavy Smoking in Psoriasis Patients Delays Age of Onset of Psoriatic Arthritis and May Protect Against Disease Development, Society of Investigative Dermatology, 1/1/2011
Heavy Smoking in Psoriasis Patients Delays Age of Onset of Psoriatic Arthritis and May Protect Against Disease Development
Zaghi D, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), 1/1/2010
Down-Regulation of Connexin-43 in Chronic Cardiac Allograft Rejection
Zaghi D, Polovaram L, et al, 32nd Annual Western Medical Student Research Forum, 1/1/2004
Join now to see all